Guardian Pharmacy ServicesGRDN -0.24%42 5-Year ROIIC % is 18.33 as of Dec. 2025. GuruFocus rates GRDN with a GF Score™ of 42/100. The stock has 4 warning signs investors should review. Among 534 Healthcare Providers & Services companies, Guardian Pharmacy Services ranks better than 76.59% on this metric.
5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year.
Guardian Pharmacy Services's 5-Year ROIIC % for the quarter that ended in Dec. 2025 was 18.33%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Guardian Pharmacy Services's 5-Year ROIIC % or its related term are showing as below:
GRDN's 5-Year ROIIC % is ranked better than 76.59% of 534
companies
in the Healthcare Providers & Services industry
Industry Median: 3.33
vs GRDN: 18.33
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Guardian Pharmacy Services 5-Year ROIIC % Related Terms
Guardian Pharmacy Services 5-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GRDN vs ACHC, ASTH, NHC: 5-Year ROIIC % Comparison
For the Medical Care Facilities subindustry, Guardian Pharmacy Services's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guardian Pharmacy Services 5-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Guardian Pharmacy Services's 5-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Guardian Pharmacy Services's 5-Year ROIIC % falls into.
5-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
5-Year Incremental Invested Capital**
=
( 48.4770268 (Dec. 2025) - 32.946 (Dec. 2020) )
/
( 235.521 (Dec. 2025) - 150.8 (Dec. 2020) )
=
15.5310268
/
84.721
=
18.33%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Guardian Pharmacy Services (GRDN) has a 5-Year ROIIC % of 18.33 as of Dec. 2025. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Guardian Pharmacy Services and its competitors. According to the industry distribution chart, Guardian Pharmacy Services ranks #125 out of 534 companies in the Healthcare Providers & Services industry, placing it in the top 23.4%.
Is Guardian Pharmacy Services' 5-Year ROIIC % too high?
Guardian Pharmacy Services' current 5-Year ROIIC % is 18.33. The Healthcare Providers & Services industry median 5-Year ROIIC % is 3.33. Guardian Pharmacy Services' value of 18.33 is 450.5% above this industry median. Based on the distribution chart, Guardian Pharmacy Services ranks #125 out of 534 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Guardian Pharmacy Services has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Guardian Pharmacy Services' 5-Year ROIIC % compare to ACHC and ASTH?
According to the Healthcare Providers & Services industry distribution chart, Guardian Pharmacy Services ranks #125 out of 534 companies for 5-Year ROIIC %. This places Guardian Pharmacy Services in the top 23% of its industry — outperforming the majority of peers. The industry median 5-Year ROIIC % is 3.33. Guardian Pharmacy Services' value of 18.33 is 450.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year ROIIC % for a Healthcare Providers & Services company?
The median 5-Year ROIIC % among Healthcare Providers & Services companies is 3.33, based on 534 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guardian Pharmacy Services's current 5-Year ROIIC % of 18.33 is 450.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year ROIIC % mean?
A high 5-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Guardian Pharmacy Services and its competitors. For the Healthcare Providers & Services industry, the median 5-Year ROIIC % is 3.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guardian Pharmacy Services's current 5-Year ROIIC % is 18.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guardian Pharmacy Services stock overvalued right now?
Guardian Pharmacy Services (GRDN) has a current 5-Year ROIIC % of 18.33. The current 5-Year ROIIC % is 18.33 and 450.5% above the Healthcare Providers & Services industry median of 3.33. Guardian Pharmacy Services' overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year ROIIC % calculated?
5-Year ROIIC % is calculated from a company's financial statements. For Guardian Pharmacy Services (GRDN), the current 5-Year ROIIC % is 18.33 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.
42GF Score
Get the complete analysis for GRDN
5-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GRDN has been successfully added to your 
